NCT05483634View on ClinicalTrials.gov

Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
MenopausePlatelet-rich PlasmaEstrogen Replacement TherapyVaginal Atrophy
Interventions
DRUG

Vaginal estrogen supplement

Daily vaginal estrogen supplement, then twice per week. Continue for three months.

PROCEDURE

Platelet-rich plasma injection

Monthly platelet-rich plasma injection for three months

Trial Locations (1)

104

MacKay Memorial Hospital, Taipei

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER

NCT05483634 - Compare Vaginal Estrogen and Platelet-rich Plasma Over Women With Genitourinary Syndrome of Menopause | Biotech Hunter | Biotech Hunter